Pharmacology postgraduate scholar at the Central University of Punjab. Passionate about translating complex pharmaceutical datasets into actionable insights.
My name is Alimam Ansari. I am a passionate M.Pharm student at the Central University of Punjab with a consistent goal of merging pharmaceutical knowledge with data science. From qualifying GPAT (2023 & 2024), CUET-PG (2024), and NIPER-JEE (2024), to diving into real-world AI projects – I strongly believe in learning with purpose and moving forward with persistence.
With a strong foundation in pharmacy and a deep interest in technology, I am currently working on an AI Medical Assistant project. My journey from the Bihar School Examination Board (10th & 12th) to pursuing B.Pharm from RGPV Bhopal, and now M.Pharm, has been guided by curiosity and a desire to innovate.
🎯 Career Vision: I want to become a Data Scientist in the healthcare domain, where I can bridge the gap between pharmaceutical science and emerging technologies. I envision building intelligent systems that improve patient outcomes, streamline prescription safety, and empower healthcare professionals.
Specialized study in disease pathways, ion channels, neuro-endocrinology, and therapeutic drug mechanisms.
Transforming complex biological datasets into clear narratives using custom python workflows and interactive dashboard configurations.
Constructing clean, mobile-responsive websites and automating clinical documentation workflows using modern tech stacks.
Diabetic neuropathy (DN) represents a major long-term microvascular complication of diabetes mellitus, resulting in chronic neuropathic pain, sensory impairments, and patient discomfort. This comprehensive review examines the vital role of key ion channel families in sensory hyperexcitability and disease pathology. Specifically, voltage-gated sodium (Nav), calcium (Cav), and potassium (Kv) channel dysregulation, alongside TRP, P2X/P2Y, and PIEZO channels are investigated under conditions of sustained hyperglycemia and chronic oxidative stress.
Modern pharmacology is witnessing a pivotal transition from single-channel pharmaceutical blockades to synergistically optimized multi-target therapies (such as co-administering KCNQ activators with Nav inhibitors). The paper evaluates these clinical strategies alongside next-generation nanocarrier delivery methodologies and gene modulation techniques, offering a definitive therapeutic roadmap while highlighting persistent challenges in channel-selectivity and bio-distribution.
Postgraduate scholar focusing deeply on Pharmacology, neuro-pharmacological pathways, computational models, and literature reviews. Investigating the potential of therapeutic modulation in voltage-gated ion channels.
Graduated with honors from a prestigious technological university. Completed comprehensive undergraduate training in core domains including Biochemistry, Organic/Medicinal Chemistry, Advanced Pharmacology, Pharmacognosy, and Pharmaceutical Analysis. Accomplished hands-on laboratory research and industrial training.
Pursued secondary schooling focused on physical and life sciences (Physics, Chemistry, Biology, and Mathematics). Graduated with high distinction, establishing a solid scientific base for undergraduate pharmaceutical studies.
Completed secondary education with high distinction, scoring strong credentials in mathematics, general science, and languages.